Gartner crashed 20.9% on 6.7× volume after guiding FY26 EPS to $12.30 (down 6.6% from $13.17 in FY25) with EBITDA margins compressing 130bps to 23.5%. The stock now trades at $160, down 70% from 52-week highs, at 10.9× forward earnings for a business generating 24% ROIC and $1.2B free cash flow.
The selloff prices in permanent impairment. The question is whether management's "more change than ever in 20 years" transformation delivers or whether this is a melting ice cube.
What Changed
Contract value growth stalled at 1% YoY, dragged by Federal government exposure (DOGE uncertainty, all 1-year contracts). Ex-Federal CV grew 4%, pointing to core business health. Management guided to CV growth acceleration through 2026 but offered no specific milestones.
The transformation spans four dimensions: impact, volume, timeliness, and user experience of insights. The only measurable early signal is AskGartner (AI product rolled out October 2025), where clients who renewed after getting access showed "significantly higher" renewal rates. No numbers disclosed. Too early to validate.
Margin compression reflects investment in the transformation: low single-digit headcount growth in sales, mid-single-digit in business developers. They're betting on productivity gains from AI-enabled workflows, but results lag spending by quarters.
The Setup
Director Stephen Pagliuca bought $9.9M at $229 on December 10, 2025. Stock is now $160, down 30% from his entry. Either he was catastrophically early or the market is pricing in a scenario he doesn't see.
The company bought back $2B in 2025 (≈8% of shares) and refreshed the authorization to $1.2B. At $160, they're repurchasing at a 40% discount to Pagliuca's December entry. If the transformation works, these buybacks will compound value. If it doesn't, they're burning cash on a declining business.
The Risk
This is a subscription business with 96%+ retention, 140% free cash flow conversion, and strong unit economics. The thesis for permanent impairment requires believing:
- The transformation fails (possible)
- Federal government cuts are permanent and spread to commercial (questionable)
- Contract value growth never reaccelerates (would contradict 4% ex-Federal growth)
- Competitors take share (no evidence in transcript)
More likely: The market is pricing in the uncertainty premium of a transformation with no clear milestones. Management guided conservatively, flagged macro headwinds (tariffs, DOGE, oil prices), and offered no near-term catalyst. In that environment, sell first and ask questions later.
Where's the Edge?
The AskGartner renewal rate signal is the only forward-looking data point. If clients who use the AI product renew at materially higher rates, that validates the transformation thesis. But management didn't quantify "significantly higher," and the sample period is only October-December renewals.
The real question: Is 10.9× forward earnings fair value for a business generating $1.2B FCF with 24% ROIC, or is this a value trap on a company whose moat is eroding?
You're buying the transformation thesis at a 40% discount to where an insider deployed $10M two months ago. If CV growth reaccelerates and margins stabilize, this reprices quickly. If the transformation stalls, you own a melting ice cube at 11× earnings.
The Federal government overhang is known and flagged. Ex-Federal grew 4%. The selloff assumes Federal cuts spread to commercial or that the transformation burns cash without delivering results. Neither is confirmed.
Valuation: 10.9× forward P/E, 23.5% EBITDA margins (down from 24.8%), $1.2B FCF, 96%+ retention, 24% ROIC
Signal convergence: Insider bought $10M at $229 (now $160), RSI 19 (extreme oversold), 70% off highs, capitulation volume
Catalyst timeline: Uncertain — management guided to CV growth acceleration through 2026 but offered no milestones
Risk: Transformation fails, Federal cuts spread to commercial, or CV growth never reaccelerates
// comments (0)